S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
NYSE:CB

Chubb (CB) Stock Price, News & Analysis

$250.21
+4.82 (+1.96%)
(As of 04/19/2024 ET)
Today's Range
$244.97
$250.63
50-Day Range
$243.46
$260.20
52-Week Range
$183.71
$260.58
Volume
2.57 million shs
Average Volume
1.37 million shs
Market Capitalization
$101.58 billion
P/E Ratio
11.46
Dividend Yield
1.37%
Price Target
$266.37

Chubb MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.56 Rating Score
Upside/​Downside
6.5% Upside
$266.37 Price Target
Short Interest
Healthy
0.59% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.65
Upright™ Environmental Score
News Sentiment
0.71mentions of Chubb in the last 14 days
Based on 24 Articles This Week
Insider Trading
Selling Shares
$29.77 M Sold Last Quarter
Proj. Earnings Growth
9.32%
From $21.13 to $23.10 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.81 out of 5 stars

Finance Sector

71st out of 840 stocks

Fire, Marine, & Casualty Insurance Industry

4th out of 49 stocks

CB stock logo

About Chubb Stock (NYSE:CB)

Chubb Limited provides insurance and reinsurance products worldwide. The company's North America Commercial P&C Insurance segment offers commercial property, casualty, workers' compensation, package policies, risk management, financial lines, marine, construction, environmental, medical risk, cyber risk, surety, and casualty; and group accident and health insurance to large, middle market, and small commercial businesses. Its North America Personal P&C Insurance segment provides affluent and high net worth individuals and families with homeowners, automobile and collector cars, valuable articles, personal and excess liability, travel insurance, and recreational marine insurance and services. The company's North America Agricultural Insurance segment offers multiple peril crop and crop-hail insurance; and coverage for farm, ranch, and specialty property and casualty, and commercial agriculture products. Its Overseas General Insurance segment provides coverage for traditional commercial property and casualty; specialty categories, such as financial lines, marine, energy, aviation, political risk, and construction; and group accident and health, and traditional and specialty personal lines for corporations, middle markets, and small customers through retail brokers, agents, and other channels. The company's Global Reinsurance segment offers traditional and specialty reinsurance under the Chubb Tempest Re brand to property and casualty companies. Its Life Insurance segment provides protection and savings products comprising whole life, endowment plans, individual and life, group term life, health protection, personal accident, credit life, universal life, group employee benefits, and unit linked contracts. It markets its products primarily through insurance and reinsurance brokers. The company was formerly known as ACE Limited and changed its name to Chubb Limited in January 2016. Chubb Limited was incorporated in 1985 and is headquartered in Zurich, Switzerland.

CB Stock Price History

CB Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Breaking down Dolphins' picks in The Athletic's 7-round mock
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Chubb (CB) Gets a Hold from Morgan Stanley
Chubb (CB) Scheduled to Post Earnings on Tuesday
16 Best Dividend Stocks of All Time
Chubb (NYSE:CB) PT Raised to $254.00
Chubb (NYSE:CB) PT Raised to $281.00
Chubb is Oversold
Chubb (NYSE:CB) Price Target Raised to $297.00
What the Dolphins starting lineup looks like after free agency
See More Headlines
Receive CB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chubb and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/30/2024
Ex-Dividend for 4/5 Dividend
3/14/2024
Dividend Payable
4/05/2024
Today
4/20/2024
Next Earnings (Confirmed)
4/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Fire, marine, & casualty insurance
Sub-Industry
N/A
Employees
40,000
Year Founded
1882

Price Target and Rating

Average Stock Price Target
$266.37
High Stock Price Target
$297.00
Low Stock Price Target
$215.00
Potential Upside/Downside
+6.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.56
Research Coverage
18 Analysts

Profitability

Net Income
$9.03 billion
Pretax Margin
19.15%

Debt

Sales & Book Value

Annual Sales
$49.74 billion
Cash Flow
$23.74 per share
Book Value
$156.11 per share

Miscellaneous

Free Float
402,495,000
Market Cap
$101.58 billion
Optionable
Optionable
Beta
0.62

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Should I Buy Chubb Stock? CB Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Chubb Limited:

  • Chubb Limited provides a diverse range of insurance and reinsurance products globally, offering stability and potential for growth in various market conditions.
  • The company's strong presence in North America and overseas markets provides geographic diversification, reducing risk exposure to specific regions.
  • Recent insider activity, such as executives selling shares at higher prices, may indicate confidence in the company's future performance.
  • Chubb's focus on specialty insurance categories like cyber risk and financial lines positions it well to capitalize on emerging trends and evolving risks in the industry.
  • With a history of acquisitions and strategic partnerships, Chubb has demonstrated a commitment to expanding its market reach and enhancing its product offerings.

Cons

Investors should be bearish about investing in Chubb Limited for these reasons:

  • Chubb's stock price may be influenced by external factors such as regulatory changes, economic downturns, or catastrophic events, impacting short-term returns.
  • The insurance industry is highly competitive, leading to pricing pressures and potential margin compression for companies like Chubb.
  • Global economic uncertainties and geopolitical risks could affect Chubb's operations in different regions, introducing volatility to its financial performance.
  • Investors should carefully monitor interest rate movements as they can impact Chubb's investment income and profitability, especially in a rising rate environment.
  • While Chubb has a strong track record, past performance is not indicative of future results, and market conditions can change rapidly, affecting investment outcomes.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 10, 2024. Please send any questions or comments about these Chubb pros and cons to contact@marketbeat.com.

CB Stock Analysis - Frequently Asked Questions

Should I buy or sell Chubb stock right now?

18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Chubb in the last twelve months. There are currently 9 hold ratings, 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CB shares.
View CB analyst ratings
or view top-rated stocks.

What is Chubb's stock price target for 2024?

18 brokers have issued 12-month target prices for Chubb's stock. Their CB share price targets range from $215.00 to $297.00. On average, they expect the company's share price to reach $266.37 in the next year. This suggests a possible upside of 6.5% from the stock's current price.
View analysts price targets for CB
or view top-rated stocks among Wall Street analysts.

How have CB shares performed in 2024?

Chubb's stock was trading at $226.00 at the start of the year. Since then, CB shares have increased by 10.7% and is now trading at $250.21.
View the best growth stocks for 2024 here
.

Are investors shorting Chubb?

Chubb saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 2,360,000 shares, a decrease of 7.5% from the March 15th total of 2,550,000 shares. Based on an average trading volume of 1,720,000 shares, the short-interest ratio is currently 1.4 days. Currently, 0.6% of the shares of the company are short sold.
View Chubb's Short Interest
.

When is Chubb's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 23rd 2024.
View our CB earnings forecast
.

How can I listen to Chubb's earnings call?

Chubb will be holding an earnings conference call on Wednesday, April 24th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Chubb's earnings last quarter?

Chubb Limited (NYSE:CB) released its quarterly earnings results on Tuesday, January, 30th. The financial services provider reported $8.30 EPS for the quarter, beating the consensus estimate of $5.07 by $3.23. The financial services provider had revenue of $13.38 billion for the quarter, compared to analyst estimates of $12.88 billion. Chubb had a trailing twelve-month return on equity of 16.45% and a net margin of 18.11%.

How often does Chubb pay dividends? What is the dividend yield for Chubb?

Chubb declared a quarterly dividend on Thursday, February 22nd. Shareholders of record on Friday, March 15th will be paid a dividend of $0.86 per share on Friday, April 5th. This represents a $3.44 annualized dividend and a yield of 1.37%. The ex-dividend date of this dividend is Thursday, March 14th.
Read our dividend analysis for CB
.

Is Chubb a good dividend stock?

Chubb (NYSE:CB) pays an annual dividend of $3.44 per share and currently has a dividend yield of 1.40%. The company has been increasing its dividend for 30 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 15.76%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CB will have a dividend payout ratio of 14.89% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CB.

How will Chubb's stock buyback program work?

Chubb announced that its board has authorized a stock repurchase program on Monday, June 12th 2023, which permits the company to repurchase $5,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to reacquire up to 6.4% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's management believes its stock is undervalued.

What is Evan Greenberg's approval rating as Chubb's CEO?

395 employees have rated Chubb Chief Executive Officer Evan Greenberg on Glassdoor.com. Evan Greenberg has an approval rating of 80% among the company's employees.

What other stocks do shareholders of Chubb own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chubb investors own include AbbVie (ABBV), Johnson & Johnson (JNJ), AT&T (T), Chevron (CVX), JPMorgan Chase & Co. (JPM), Cisco Systems (CSCO), Intel (INTC), Walmart (WMT), Exxon Mobil (XOM) and McDonald's (MCD).

Who are Chubb's major shareholders?

Chubb's stock is owned by a variety of institutional and retail investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.28%), Confluence Investment Management LLC (0.16%), Los Angeles Capital Management LLC (0.15%), Wealth Enhancement Advisory Services LLC (0.05%), Factory Mutual Insurance Co. (0.03%) and Rockland Trust Co. (0.03%). Insiders that own company stock include Annmarie T Hagan, Evan G Greenberg, Evan G Greenberg, John J Lupica, John W Keogh, Joseph F Wayland, Joseph F Wayland, Juan Luis Ortega, Michael G Atieh, Michael G Atieh, Paul J Krump, Sean Ringsted, Theodore Shasta and Timothy Alan Boroughs.
View institutional ownership trends
.

How do I buy shares of Chubb?

Shares of CB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CB) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners